MGUS – monoclonal gammopathy of undetermined significance | Blood Cancer UK
Monoclonals - an overview | ScienceDirect Topics
Paraproteinaemic neuropathy: MGUS and beyond | Practical Neurology
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study - The Lancet Haematology
Immunofixation - an overview | ScienceDirect Topics
Episode 040: Myeloma Series, Pt.1 - Intro to Testing and MGUS — The Fellow On Call
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
Monoclonal gammopathy and primary care | British Columbia Medical Journal
Risk Stratifying Patients with Monoclonal Gammopathy of Undetermined Significance – Consult QD
Pseudo-monoclonal gammopathy: a report of four cases | Haematologica
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation